Table 4. : Assessment of visual analog pain scale score between groups.
Group | Visit 1 | Visit 2 | Visit 3 | Visit 4 |
EnMax(n=26) | 6.538± 0.508 | 1.769±1.904* (72.94%) | 1.231±1.632* (81.18%) | 0.308±0.679* (95.29%) |
Marketed reference (n=13) | 6.231±0.725 | 2.231±1.363* (64.20%) | 1.154±1.345 (81.48%) | 0.846±1.463 (86.42%) |
$P-value | 0.263 | 0.232 | 0.542 | 0.107 |
Placebo (n=26) | 6.346±0.629 | 3.654±2.097* (42.42%) | 3.423±2.230* (46.06 %) | 1.462±1.174* (76.97 %) |
#P-value | 0.358 | < 0.001 | 0.001 | 0.001 |